Cargando…
Hepatocellular Carcinoma in Sub-Saharan Africa
More than 80% of global hepatocellular carcinoma (HCC) patients are estimated to occur in sub-Saharan Africa (SSA) and Eastern Asia. The most common risk factor of HCC in SSA is chronic hepatitis B virus (HBV) infection, with the incidence highest in West Africa. HBV is highly endemic in SSA and is...
Autores principales: | Kedar Mukthinuthalapati, V. V. Pavan, Sewram, Vikash, Ndlovu, Ntokozo, Kimani, Stephen, Abdelaziz, Ashraf Omar, Chiao, Elizabeth Yu, Abou-Alfa, Ghassan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457845/ https://www.ncbi.nlm.nih.gov/pubmed/34043413 http://dx.doi.org/10.1200/GO.20.00425 |
Ejemplares similares
-
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers
por: Lin, Lilie L., et al.
Publicado: (2020) -
Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma
por: Mukthinuthalapati, V. V. Pavan Kedar, et al.
Publicado: (2023) -
Toward Optimization of Cancer Care in Sub-Saharan Africa: Development of National Comprehensive Cancer Network Harmonized Guidelines for Sub-Saharan Africa
por: Mutebi, Miriam, et al.
Publicado: (2020) -
Africa Guidelines for Hepatocellular Carcinoma Buildup Process
por: Abou-Alfa, Ghassan K., et al.
Publicado: (2023) -
A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa
por: Kambhampati, Aparna, et al.
Publicado: (2023)